Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals

Journal of Sexual Medicine

Volumn 11, Issue 5, 2014, Pages 1248-1261

  Zubiaurre Elorza, Leire ^a,b   Junque, Carme ^a,b   Gómez Gil, Esther ^a,c   Guillamon, Antonio ^d  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d UNIVERSIDAD NACIONAL DE EDUCACIÓN A DISTANCIA   (Spain)

Author keywords

Anabolic steroids; Antiandrogens; Cortical thickness; Cross sex hormone therapy; Estrogens; Gender dysphoria; Gender identity disorders; MRI; Sex steroid hormone therapy; Testosterone; Transsexuals

Indexed keywords

ANTIANDROGEN; ESTROGEN; SEX HORMONE; TESTOSTERONE;

ADULT; ANDROGEN THERAPY; ARTICLE; BRAIN SIZE; CLINICAL ARTICLE; CORTICAL THICKNESS (BRAIN); CUNEUS; FEMALE; FEMALE TO MALE TRANSSEXUAL; FRONTAL LOBE; GLOBUS PALLIDUS; GRAY MATTER; HORMONAL THERAPY; HUMAN; IMAGING SOFTWARE; LEFT HEMISPHERE; LONGITUDINAL STUDY; MALE; MALE TO FEMALE TRANSSEXUAL; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; POSTCENTRAL GYRUS; PRIORITY JOURNAL; RIGHT HEMISPHERE; TESTOSTERONE BLOOD LEVEL; THALAMUS; THERAPY EFFECT; TRANSSEXUALITY; VOLUMETRY;

ANABOLIC STEROIDS; ANTIANDROGENS; CORTICAL THICKNESS; CROSS-SEX HORMONE THERAPY; ESTROGENS; GENDER DYSPHORIA; GENDER IDENTITY DISORDERS; MRI; SEX STEROID HORMONE THERAPY; TESTOSTERONE; TRANSSEXUALS;

ADULT; ANDROGEN ANTAGONISTS; ANDROGENS; BRAIN; ESTROGENS; FEMALE; GONADAL STEROID HORMONES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; TESTOSTERONE; TRANSSEXUALISM; YOUNG ADULT;

EID: 84899484084     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12491     Document Type: Article

References (97)

1. Luders E, Sánchez FJ, Gaser C, Toga AW, Narr KL, Hamilton LS, Vilain E. Regional gray matter variation in male-to-female transsexualism. Neuroimage 2009;46:904-907.
2. Luders E, Sánchez FJ, Tosun D, Shattuck DW, Gaser C, Vilain E, Toga AW. Increased cortical thickness in male-to-female transsexualism. J Behav Brain Science 2012;2:357-362.
3. Rametti G, Carrillo B, Gómez-Gil E, Junque C, Segovia S, Gomez A, Guillamon A. White matter microstructure in female to male transsexuals before cross-sex hormonal treatment. A diffusion tensor imaging study. J Psychiatr Res 2011;45:199-204.
4. Rametti G, Carrillo B, Gómez-Gil E, Junque C, Zubiaurre-Elorza L, Segovia S, Gomez A, Guillamon A. The microstructure of white matter in male to female transsexuals before cross-sex hormonal treatment. A DTI study. J Psychiatr Res 2011;45:949-954.
5. Savic I, Arver S. Sex dimorphism of the brain in male-to-female transsexuals. Cereb Cortex 2011;21:2525-2533.
6. Zubiaurre-Elorza L, Junque C, Gómez-Gil E, Segovia S, Carrillo B, Rametti G, Guillamon A. Cortical thickness in untreated transsexuals. Cereb Cortex 2013;23:2855-2862.
7. Puy L, MacLusky NJ, Becker L, Karsan N, Trachtenberg J, Brown TJ. Immunocytochemical detection of androgen receptor in human temporal cortex: Characterization and application of polyclonal androgen receptor antibodies in frozen and paraffin-embedded tissues. J Steroid Biochem Mol Biol 1995;55:197-209.
8. Finley SK, Kritzer MF. Immunoreactivity for intracellular androgen receptors in identified subppulations of neurons, astrocytes and oligodendrocytes in primate prefrontal cortex. J Neurobiol 1999;40:446-457.
9. Beyenburg S, Watzka M, Clusmann H, Blümcke I, Bidlingmaier F, Elger CE, Stoffel-Wagener B. Androgen receptor mRNA expression in the human hippocampus. Neurosci Lett 2000;294:25-28.
10. Österlund MK, Gustafsson J-A, Keller E. Estrogen receptor β (ERβ) messenger ribonucleic acid (mRNA) expression within the human forebrain: Distinct distribution pattern to ERα mRNA. J Clin Endocrinol Metab 2000;85:3840-3846.
11. Gonzalez M, Cabrera-Socorro A, Pérez-García CG, Fraser JD, López FJ, Alonso R, Meyer G. Distribution of estrogen receptor α and β in the human cortex and hippocampus during development and adulthood. J Comp Neurol 2007;503:790-892.
12. Montague D, Weickert CS, Tomaskovic-Crook E, Rothmond DA, Kleinman JE, Rubinow DR. Oestrogen receptor α localisation in the prefrontal cortex of three mammalian species. J Neuroendocrinol 2008;20:893-903.
13. Fernández-Guasti A, Kruijver FP, Fodor M, Swaab DF. Sex differences in the distribution of androgen receptors in the human hypothalamus. J Comp Neurol 2000;425:422-435.
14. Österlund MK, Keller E, Hurd YL. The human forebrain has discrete estrogen receptor α messenger RNA expression: High levels in the amygdaloid complex. Neuroscience 2000;95:333-342.
15. Kruijver FP, Balesar R, Espila AM, Unmehopa UA, Swaab DF. Estrogen receptor-alpha distribution in the human hypothalamus in relation to sex and endocrine status. J Comp Neurol 2002;9:115-139.
16. DonCarlos LL, Garcia-Ovejero D, Sarkey S, Garcia-Segura LM, Azcoitia I. Androgen receptor immunoreactivity in forebrain axons and dendrites in the rat. Endocrinology 2003;144:3632-3638.
17. Hulshoff Pol HE, Cohen-Kettenis PT, Van Haren NEM, Peper JS, Brans RGH, Cahn W, Schnack HG, Gooren LJG, Kahn RS. Changing your sex changes your brain: Influences of testosterone and estrogen on adult human brain structure. Eur J Endocrinol 2006;155:s107-114.
18. Rametti G, Carrillo B, Gómez-Gil E, Junque C, Zubiaurre-Elorza L, Segovia S, Gomez A, Karad K, Guillamon A. Effects of androgenization on the white matter microstructure of female-to-male transsexuals. A diffusion tensor imaging study. Psychoneuroendocrinology 2012;37:1261-1269.
19. Moore E, Wisniewski A. Dobss A. Endocrine treatment of transsexual people: A review of treatment regimes, and adverse effects. J Clin Endocrinol Metab 2003;88:3467-3473.
20. Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: Extensive personal experience. J Clin Endocrinol Metab 2008;93:19-25.
21. Gómez-Gil E, Trilla A, Salamero M, Godás T, Valdés M. Sociodemographic, clinical, and psychiatric characteristics of transsexuals from spain. Arch Sex Behav 2009;38:378-392.
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: APA; 2000.
23. World Health Organization. The ICD-10 classification of mental and behavioural disorders: Diagnostic criteria for research. Geneva: WHO; 1993.
24. Meyer W III, Bockting WO, Cohen-Kettenis P, Coleman E, DiCeglie D, Devor H, Gooren LJC, Hage JJ, Kirk S, Kuiper AJ, Laub D, Lawrence A, Menard Y, Patton J, Shaefer L, Webb A, Wheeler CC. The Harry Benjamin gender dysphoria association's standards of care for gender identity disorders, sixth version. J Psychol Hum Sex 2001;13:1-30.
25. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;10:3666-3672.
26. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A. Measurement of free testosterone in normal women and women with androgen deficiency: Comparison of methods. J Clin Endocrinol Metab 2004;89:525-533.
27. Reuter M, Schmansky NJ, Rosas HD, Fischl B. Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 2012;61:1402-1418.
28. Reuter M, Fischl B. Avoiding asymmetry-induced bias in longitudinal image processing. Neuroimage 2011;57:19-21.
29. Reuter M, Rosas HD, Fischl B. Highly accurate inverse consistent registration: a robust approach. Neuroimage 2010;53:1181-1196.
30. Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, Killiany RJ. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006;31:968-980.
31. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci 2000;97:11050-11055.
32. Kuperberg GR, Broome MR, McGuire PK, David AS, Eddy M, Ozawa F, Goff D, West WC, Williams SC, van der Kouwe AJ, Salat DH, Dale AM, Fischl B. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch Gen Psychiatry 2003;60:878-888.
33. Salat DH, Buckner RL, Snyder AZ, Greve DN, Desikan RS, Busa E, Morris JC, Dale AM, Fischl B. Thinning of the cerebral cortex in aging. Cereb Cortex 2004;14:721-730.
34. Rosas HD, Liu AK, Hersch S, Glessner M, Ferrante RJ, Salat DH, van der Kouwe A, Jenkins BG, Dale AM, Fischl B. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002;58:695-701.
35. Hojat M, Xu G. A visitor's guide to effect sizes: Statistical significance versus practical (clinical) importance of research findings. Adv Health Sci Educ Theory Pract 2004;9:241-249.
36. Sowell ER, Peterson BS, Kan E, Woods RP, Yoshii J, Bansa R, Xu D, Zhu H, Thompson PM, Toga AW. Sex differences in cortical thickness mapped in 176 healthy individuals between 7 and 87 years of age. Cereb Cortex 2007;17:1550-1560.
37. Raznahan A, Lee Y, Stidd R, Long R, Greenstein D, Clasen L, Addington A, Gogtay N, Rapoport JL, Giedd JN. Longitudinally mapping the influence of sex and androgen signaling on the dynamics of human cortical maturation in adolescence. PANAS 2010;107:16988-16993.
38. Paus T, Nawaz-Khan I, Leonard G, Perron M, Pike GB, Pitiot A, Richer L, Susman E, Veillette S, Pausova Z. Sexual dimorphism in the adolescent brain: Role of testosterone and androgen receptor in global and local volumes of grey and white matter. Horm Behav 2010;57:63-75.
39. Nguyen T-V, McCracken J, Ducharme S, Botteron KN, Mahabir M, Johanson W, Israel M, Evans AC, Karama S. Testosterone-related cortical maturation across childhood and adolescence. Cereb Cortex 2013;23:1424-1432.
40. Kravitz DJ, Saleem KS, Baker CI, Mishkin MA. New neural framework for visuospatial processing. Nat Rev Neurosci 2011;12:217-230.
41. McBain R, Norton D, Chen Y. Females excel at basic face perception. Acta Psychol 2009;130:168-173.
42. Hodzic A, Kaas A, Muckli L, Stirn A, Singer W. Distinct cortical networks for the detection and identification of human body. Neuroimage 2009;45:1264-1271.
43. Price CJ. A review and synthesis of the first 20 years of PET and fMRI studies of heard speech, spoken language and reading. Neuroimage 2012;62:816-847.
44. Traish AM, Gooren LJ. Safety of physiological testosterone therapy in women: lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy. J Sex Med 2010;7:3758-3764.
45. Österlund MK, Grandien K, Keller E, Hurd YL. The human brain has distinct regional expression patterns of estrogen receptor alpha mRNA isoforms derived from alternative promoters. J Neurochem 2000;75:1390-1397.
46. Pelletier G. Steroidogenic enzymes in the brain: Morphological aspects. Prog Brain Res 2010;181:193-207.
47. Lephart ED. A review of brain aromatase cytochrome P450. Brain Res Rev 1996;22:1-26.
48. Negri-Cesi P, Poletti A, Celotti F. Metabolism of steroids in the brain: a new insight into role of 5α-reductase and aromatase in brain differentiation and functions. J Steroid Biochem Molec Biol 1996;58:455-466.
49. Kicman AT. Pharmacology of anabolic steroids. Br J Pharmacol 2008;154:502-521.
50. Sarrieau A, Dussaillant M, Agid F, Philibert D, Agid Y, Rostene W. Autoradiographic localization of glucocorticosteroid and progesterone binding sites in the human post-mortem brain. J Steroid Biochem 1986;25:717-721.
51. Kruggel F, Bruckner MK, Arendt T, Wiggins CJ, von Cramon DY. Analyzing the neocortical fine-structure. Med Image Anal 2003;7:251-264.
52. Eickhoff S, Walters NB, Schleicher A, Kril J, Egan GF, Zilles K, Watson JD, Amunts K. High-resolution MRI reflects myeloarchitecture and cytoarchitecture of human cerebral cortex. Hum Brain Mapp 2005;24:206-215.
53. Protopopescu X, Butler T, Pan H, Root J, Altemus M, Polanecsky M, McEwen B. Hippocampal structural changes across the menstrual cycle. Hippocampus 2008;18:985-988.
54. Oatridge A, Holdcroft A, Saeed N, Hajnal JV, Puri BK, Fusi L, Bydder GM. Change in brain size during and after pregnancy: Study in healthy women and women with preeclampsia. Am J Neuroradiol 2002;23:19-26.
55. Gooren LJ, Bunck MC. Transsexuals and competitive sports. Eur J Endocrinol 2004;151:425-429.
56. Mueller A, Kiesewetter F, Binder H, Beckmann MW, Dittrich R. Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals. J Clin Endocrinol Metab 2007;92:3470-3475.
57. Gómez-Gil E, Zubiaurre-Elorza L, Esteva I, Guillamon A, Godás T, Cruz Almaraz M, Halperin I, Salamero M. Hormone-treated transsexuals report less social distress, anxiety and depression. Psychoneuroendocrinology 2012;37:662-670.
58. Kuhn CM. Anabolic steroids. Recent Prog Horm Res 2002;57:411-434.
59. Rametti G, Carrillo B, Gómez-Gil E, Junque C, Zubiaurre-Elorza L, Segovia S, Gomez A, Karadi K, Guillamon A. Effects of androgenization on the white matter microstructure of female-to-male transsexuals. A difussion tensor imaging study. Psychoneuroendocrinology 2012;37:1261-1269.
60. Slabbekoorn D, van Goozen SHM, Megens J, Gooren LJG, Cohen-Kettenis PT. Activating effects of cross-sex hormones on cognitive functioning: A study of short-term and long-term hormone effects in transsexuals. Psychoneuroendocrinology 1999;24:423-447.
61. Gómez-Gil E, Cañizares S, Torres A, de la Torre F, Halperin I, Salamero M. Androgen treatment effects on memory in female-to-male transsexuals. Psychoneuroendocrinology 2009;34:110-117.
62. Haraldsen IR, Egeland T, Haug E, Finset A, Opjorsdsmoen S. Cross-sex hormone treatment does not change sex-sensitive cognitive performance in gender identity disorder patiens. Psychiatr Res 2005;137:161-174.
63. Carrillo B, Gómez-Gil E, Rametti C, Junque C, Gomez A, Karadi K, Segovia S, Guillamon A. Cortical activation during mental rotation in male-to-female and female-to-male transsexuals under hormonal treatment. Psychoneuroendocrinology 2010;35:1213-1222.
64. Wierckx K, Elaut E, van Caenegem E, van De Peerl F, Dedecker D, van Houdenhove E, T'Sjoen G. Sexual desire in female-to-male transsexual persons: exploration of the role of testosterone administration. Eur J Endocrinol 2011;165:331-337.
65. Draganski B, May A. Training-induced structural changes in the adult human brain. Behav Brain Res 2008;192:137-142.
66. Taubert M, Draganski B, Anwander A, Müller K, Horstmann A, Villringer A, Ragert P. Dinamic properties of human brain structure: Learning-related changes in cortical areas and associated fiber connections. J Neurosci 2010;30:11670-11677.
67. May A, Gaser C. Magnetic resonance-based morphometry: A window into structural plasticity of the brain. Curr Opin Neurol 2006;19:407-411.
68. Peper JS, Brouwer RM, Schnack HG, van Baal GC, van Leeuwen M, van den Berg SM, Delemarre-Van de Waal HA, Boomsma DI, Kahn RS, Hulshoff Pol HE. Sex steroids and brain structure in pubertal boys and girls. Psychoneuroendocrinology 2009;34:332-342.
69. Osserwaarde L, van Wingen GA, Rijpkema M, Bäckström T, Hermans EJ, Fernández G. Menstrual cycle-related changes in amygdala morphology are associated with changes in stress sensitivity. Hum Brain Mapp 2013;34:1187-1193.
70. Hagemann G, Ugur T, Scheussner E, Mentzel HJ, Fitzek C, Witte OW, Gaser C. Changes in brain size during the menstrual cycle. PLosOne 2011;6:e14655.
71. Resnick SM, Espeland MA, Jaramillo SA, Hirsch C, Stefanick ML, Murray AM, Ockene J, Davatzikos C. Postmenopausal hormone therapy and regional brain volumes. Neurology 2009;72:135-142.
72. Casanova R, Espeland MA, Goveas JS, Davatzikos C, Gaussoin SA, Maldjian JA, Brunner RL, Kuller LH, Johnson KC, Mysiw WJ, Wagner B, Resnick S. Application of machine methods to describe the effects of conjugated equine estrogens therapy on region-specific brain volumes. Magn Reson Imaging 2011;29:546-553.
73. Garcia-Segura LM, Chowen JA, Párducz A, Naftolin F. Gonadal hormones as promoters of structural synaptic plasticity: Cellular mechanisms. Prog Neurobiol 1994;44:279-283.
74. Brawer JR, Beaudet A, Desjardins GC, Schipper HM. Pathologic effect of estradiol on the hypothalamus. Biol Reprod 1993;49:647-652.
75. Fishman J, Naftolin F, Davies IJ, Ryan KJ, Petro Z. Catechol estrogen formation by the human fetal brain and pituitary. J Clin Endocrinol Metab 1976;42:177-180.
76. Segovia S, Guillamon A. Sexual dimorphism in the vomeronasal pathway and sex differences in reproductive behaviors. Brain Res Rev 1993;18:51-74.
77. Guillamon A, Segovia S. Sexual dimorphism in the CNS and the role of steroids. In: Stone TW, ed. CNS neurotransmitters and neuromodulators. Boca Raton, FL: CRC Press; 1996:127-152.
78. Waters EM, Simerly RB. Estrogen induces caspase-dependent cell death during hypothalamic development. J Neurosci 2009;29:9714-9718.
79. Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, Brewer J, Dale AM. One-year brain atrophy evident in healthy aging. J Neurosci 2009;29:15223-15231.
80. Moncrieff J, Leo J. A systematic review of the effects of antipsychotic drugs on brain volume. Psycol Med 2010;40:1409-1422.
81. Kraemer GR, Kraemer RR, Ogden BW, Kilpatrick RE, Gimpel TL, Castracane VD. Variability of serum estrogens among postmenopausal women treated with the same transdermal estrogen therapy and the effect of androgens and sex hormone binding globulin. Fertil Steril 2003;79:534-542.
82. Voyer D, Voyer S, Bryden MP. Magnitude of sex differences in spatial abilities: A meta-analysis and consideration of critical variables. Psychol Bull 1995;117:250-270.
83. Van Goozen SH, Slabbekoorn D, Gooren LJ, Sanders G, Cohen-Kettenis PT. Organizing and activating effects of sex hormones in homosexual transsexuals. Behav Neurosci 2002;116:982-988.
84. Miles C, Green R, Hines M. Estrogen effects on cognition, memory and mood in male-to-female transsexuals. Horm Behav 2006;50:707-717.
85. Santarnecchi E, Vatti G, Déttore D, Rossi A. Intrinsic cerebral connectivity analysis in an untreated female-to-male transsexual subject: A first attempt using resting-state fMRI. Neuroendocrinology 2012;96:188-193.
86. Leavitt F, Berger JC, Hoeppner JA, Northrop G. Presurgical adjustement in male transsexuals with and without hormonal treatment. J Nerv Ment Dis 1980;168:693-697.
87. Gómez-Gil E, Vidal-Hagemeijer A, Salamero M. MMPI-2 characteristics of transsexuals requesting sex reassignment: Comparison of patients in prehormonal and and presurgical phases. J Pers Assess 2008;90:368-374.
88. Asscheman H, Gooren LJ, Ecklund PL. Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metab 1989;38:869-873.
89. Constantino A, Cerpolini S, Alvisi S. A prospective study of sexual function and mood in female-to-male transsexuals during testosterone administration and after sex reassignment surgery. J Sex Marital Ther 2013;39:321-325.
90. Wierckx K, Mueller S, Weyers S, Van Caenegem E, Roef G, Heylens G, T'Sjoen G. Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med 2012;9:2641-2651.
91. Zhou JN, Hofman MA, Gooren LJ, Swaab DF. A sex difference in the human brain and its relation to transsexuality. Nature 1995;378:68-70.
92. Kruijver FP, Zhou JN, Pool CW, Hofman MA, Gooren LJ, Swaab DF. Male-to-female transsexuals have female neurons numbers in a limbic nucleus. J Clin Endocrinol Metab 2000;85:2034-2041.
93. Garcia-Falgueras A, Swaab DF. A sex difference in the hypothalamic uncinate nucleus: Relationship to gender identity. Brain 2008;131:3132-3146.
94. Fjell AM, Walhovd KB. Structural brain changes in aging: Courses, causes and cognitive consequences. Rev Neurosci 2010;21:187-221.
95. Shaw P, Kabani NJ, Lerch JP, Eckstrand K, Lenroot R, Gogtay N, Greenstein D, Clasen L, Evans A, Rapoport JL, Gied JN, Wise SP. Neurodevelopmental trajectories of human cerebral cortex. J Neurosci 2008;28:3586-3594.
96. Rothman KJ. No adjustements are needed for multiple comparisons. Epidemiology 1990;1:43-46.
97. Perneger TV. What's wrong with Bonferroni adjustements. BMJ 1998;316:1236-1238.